About Us
Right Scan Right Time is a patient, survivor, and community network that aims to improve access to advanced medical imaging technologies and high-quality care. We are the leading patient advocacy organization focused on enhancing access, safety, and innovation for medical imaging. Thank you for supporting our mission by visiting this page!
We know that screening and early diagnosis saves lives and lowers costs. That’s why our organization is vocal and active about the importance of early detection and the value of medical imaging in enhancing patient health and directing patient care.
If you’re interested in receiving updates about relevant policies, imaging news, or the efforts of our advocates, sign up for our newsletter here.
For more information, contact info@rightscanrighttime.org
Imaging Saves Lives
Medical imaging has revolutionized healthcare, allowing healthcare providers to find diseases at their earliest and most treatable stage — saving countless lives and improving patient outcomes.
Our patient advocates know firsthand the benefits of imaging: from detecting cancer at an early stage to finding an arterial blockage in time to prevent a stroke. Innovations in imaging are saving lives.
The lives saved by improving access to imaging are evidenced by the stories patients tell, all of whom Right Scan Right Time is proud to showcase. The importance of access is also evidenced by constant research. Consider:
Recent studies show that reduced access to medical imaging leads to delayed diagnoses and increased mortality, while advances in imaging technology continue to improve early detection and life-saving clinical decision-making.
- Earlier, regular mammogram screenings for women aged 40 are attributed to a ~41.7% mortality reduction (RSNA).
- Low-dose computed tomography (LDCT) thorax imaging detects lung cancer at an earlier stage, leading to better survival outcomes (NIH).
- Routine screening for precancerous polyps can detect cancer sooner when it’s easier to treat. About 89% of adults diagnosed with colorectal cancer at the earliest stage live for 5 years or more, compared to only 16% diagnosed at the most advanced stage (CDC).